Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-23

Clinical Trial Update: Suvorexant and Alcohol [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 study is investigating suvorexant for Alcohol Use Disorder. Enrollment is currently RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Suvorexant (suvorexant)

Snippet

Sponsor: William Stoops | Conditions: Alcohol Use Disorder | EARLY_Phase 1 | Status: RECRUITING